AN UPDATE ON THE PROGRESS OF OUR RESEARCH WORK. SEPT-CAM SARL BP 8324 YAOUNDE CAMEROUN Tel +237 6 73 47 47 62 71 or +237 2 43 02 54 27 Website. www.septcam.com
Read more at http://www.septwebcam.com/pages/le-point-sur-l-avancement-de-nos-travaux-de-recherche.html#7yQXHItzxwAKM7z2.99

To the Director of Publication of Cameroon Tribune…………………………………………………………………………………………………………………………………………,

In February 2005 and more precisely on the 3rd of the month, you had to publish in your publication a part of our activity report on our scientific research work on the natural treatment of viral diseases, part relating to the natural treatment of HIV/AIDS. In this publication, we reported rare cases of HIV-HEPATITE B co-infection successfully treated using our natural antivirals.From January 2006, we focused our research almost exclusively on the natural treatment of viral hepatitis A, B and C, temporarily abandoning HIV-AIDS because, with the arrival of free antiretrovirals, many patients had stopped taking our expensive and yet effective antivirals to take ARVs distributed free of charge and yet lifelong treatment. Today, our research on the natural treatment of viral hepatitis has produced results that exceed our expectations.

        Indeed, until 2007, our natural antivirals only allowed us to control viral hepatitis A, B and C by protecting the liver without actually healing them. Only hepatitis A and other high transaminase hepatic deficiencies were easily treated. We are proud to announce to the world that our laboratory has developed two natural antivirals HEPVICOMB and HEPVIMIX to cure hepatitis B and C respectively. With HEPVICOMB, it takes on average 2 months to overcome hepatitis B. With HEPVIMIX, it takes on average 4 months to overcome hepatitis C regardless of the GENOTYPE. We are currently conducting concentration studies for HEPVIMIX to reduce the average duration of treatment. Our products are also effective in case of HEPATITE B-HEPATITE C co-infection. In this case, we found that hepatitis B disappears faster than hepatitis C. We are also studying other cases of co-infection such as – VIH/HEPATITE B – VIH/HEPATITE C and – VIH/HEPATITE B and C Mr. Director, we invite you to visit our website www.septcam.com Please accept, Mr. Director, the assurance of our best regards./ …………………………………………………………………………………………………………………………………………………………………………………………………………………………………….. Done at Buea, 19 May 2010 …………………………………………………………………………………………………………………………… Dr SEUNKAM DG SEPT-CAM SARL.